BNET Industries

Enzo Biochem Inc.

(ENZ) is in the Health Care Industry

Market Cap:$203.6M
Last Fiscal Year Sales:$77.7M
  • Public
  • US
Dow Jones Description

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools and therapeutics and the provision of diagnostic services to the medical community. Since its founding in 1976, Enzos strategic focus has been on the development, for commercial purposes, of enabling technologies in the life sciences field. Enzos pioneering work in genomic analysis coupled with its extensive patent estate and enabling platforms have strategically positioned Enzo to play a crucially important role in the rapidly growing life sciences and molecular medicine marketplaces. We are comprised of three operating companies that have evolved out of our core competence: the use of nucleic acids as informational molecules and the use of compounds for immune modulation. These wholly owned operating companies conduct their operations through three reportable segments. Below are brief descriptions of each of the three operating segments (see Note 13 in the notes to consolidated financial statements): Enzo Life Sciences is a company that manufactures, develops and markets functional biology and cellular biochemistry products and tools to research and pharmaceutical customers world-wide and has amassed a large patent and technology portfolio. ...

Chairman & CEO
Elazar Rabbani
Number of Employees 439
Contact Information

527 Madison Ave

New York, New York 10022-4304

enzo.com

(631) 755-5500

NAICS Code Medical Laboratories: 621511

Recent Events

  • Enzo Biochems Clinical Lab Enters Exclusive Agreement with GeneNews to Market Blood Test for Colorectal...

    11/18/09 - Joint Venture / Alliance - View Story

  • Where the hardware meets wetware

    11/05/09 - Product Announcement - View Story

  • Enzo Biochem 4Q loss widens on costs

    10/14/09 - Financial Announcement - View Story

  • Enzo Biochem and BioTek Instruments Forge Co-Marketing Partnership

    10/09/09 - Product Announcement - View Story

  • NIH and Enzo Biochem to Conduct Clinical Trial with Optiquel

    9/23/09 - Joint Venture / Alliance - View Story

  • Enzo Biochems Life Sciences Unit Introduces Novel System for

    9/17/09 - Product Announcement - View Story

  • Enzo Biochem Appoints Dr. Mohan Chellani, 15-Year Industry Veteran, Vice President of Scientific Affairs at...

    9/08/09 - Mgmt. Change Entering - Other - View Story

News & Analysis

enzo biochem inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Barry W. Weiner President, Chief Financial Officer and Director
Christine Fischette President, Enzo Therapeutics, Inc.
Andrew Whiteley Chief Operating Officer, Enzo Life Sciences and Vice President of Business Development
Shahram K. Rabbani COO, Treasurer & Secretary
Dean Engelhardt Executive Vice President
Andrew R. Crescenzo Senior Vice President, Finance
Norman E. Kelker Senior Vice President
Barbara E. Thalenfeld Vice President, Corp Dev
David C. Goldberg Vice President, Business Dev
Herbert B. Bass Vice President, Finance
Melvin F. Lazar Lead Director
Natalie Bogdanos General Counsel
Bernard L. Kasten Director

Board of Directors

Name (plus bio) Position
Elazar Rabbani Chairman & CEO
Carl Balezentis Board of Directors
Gary C Cupit Board of Directors
Irwin C. Gerson Board of Directors
John J. Delucca Board of Directors
Ronald C Fedus Esq Board of Directors
Stephen B. H. Kent Board of Directors

Dr. Elazar Rabbani, Ph.D., Enzo Biochem's founder has served as the Company's Chairman of the Board of Directors and Chief Executive Officer since its inception in 1976. Dr. Rabbani has authored numerous scientific publications in the field of molecular biology, in particular, nucleic acid labeling and detection. He is also the lead inventor of many of the company's pioneering patents covering a wide range of technologies and products. Dr. Rabbani received his Bachelor of Arts degree from New York University in Chemistry and his Ph.D. in Biochemistry from Columbia University. He is a member of the American Society for Microbiology.

Organization Position Status
Enzo Biochem Inc. Chairman & CEO Current
Enzo Biochem Inc. Founder Current
Columbia University Ph.D. In Biochemistry Former
New York University Bachelor of Arts Degree Former

BARRY W. WEINER (age 58) President, Chief Financial Officer and Director, is a founder of Enzo Biochem, Inc. He has served as the Company s President since 1996, and previously held the position of Executive Vice President. Before his employment with Enzo, he worked in several managerial and marketing positions at the Colgate Palmolive Company. Mr. Weiner is a Director of the New York Biotechnology Association. He received his Bachelor of Arts degree in Economics from New York University and a Master of Business Administration in Finance from Boston University.

Organization Position Status
Enzo Biochem Inc. President, Chief Financial Officer and Director Current
Enzo Clinical Labs Inc. Current
Enzo Biochem Inc. Board of Directors Current
Enzo Biochem Inc. Founder Former
Colgate-Palmolive Company Former
Boston University Master of Business Administration In Finance Former
New York University Bachelor of Arts Degree In Economics Former

DR. CHRISTINE T. FISCHETTE (age 57) President, Enzo Therapeutics, Inc. has held this position since January 2008. Before her employment with Enzo, from 1999-2007 she was Executive Director and Head of Negotiation, Global Business Development and Licensing for various therapeutic Business Franchise Boards at Novartis Pharmaceuticals, a division of Novartis Ag. From 1987 1999, Dr. Fischette has held various positions at Pfizer Pharmaceuticals, NY and directed preclinical/clinical development, medical marketing, and was head of Pfizer s US commercial arm for diabetes before joining business development and licensing from 1987-1999. Prior to her work experience at Pfizer, she conducted research as Senior Scientist at Hoffmann-La Roche, Inc. and as a PostDoctoral Fellow at Rockefeller University. Dr. Fischette holds a Ph.D. in Physiology from the University of Medicine & Dentistry of New Jersey and a B.A. in Biology Education from Rutgers University.

Organization Position Status
Enzo Biochem Inc. President, Enzo Therapeutics, Inc. Current
West Membership Co Head, Negotiation, Novartis Pharmaceuticals Corporation Current
Pfizer Inc. Current
University of Medicine and Dentistry of New Jersey Ph.D. Former
Dentistry.Com Ph.D. Former
Rutgers University B.A. In Biology Education Former

Organization Position Status
Vitra Bioscience, Inc. CEO, Vitra Bioscience, Inc. Current
Enzo Biochem Inc. Chief Operating Officer, Enzo Life Sciences and Vice President of Business Development Current
Enzo Biochem Inc. Board of Directors Current
Informax Inc. CEO Former
Vitra Ltd CEO Former
Bioinformatics, Inc. Vice President Former
Informax Inc. Chairman Former
Informax Inc. board director Former
Chemistry, LLC Degree In Biochemistry Former
University of Nottingham Degree In Biochemistry Former

Organization Position Status
Enzo Clinical Labs Inc. President Current
Enzo Biochem Inc. COO, Treasurer & Secretary Current
Enzo Biochem Inc. Board of Directors Current
Enzo Biochem Inc. Treasurer & Secretary Former
Adelphi University Bachelor of Arts Degree In Chemistry Former

Organization Position Status
Enzo Biochem Inc. Executive Vice President Current

Organization Position Status
Enzo Biochem Inc. Senior Vice President, Finance Current
Enzo Biochem Inc. Board of Directors Current
Adelphi University Bachelor of Business Administration, Accounting Former

Norman E. Kelker, Ph.D., Senior Vice President at Enzo Biochem, has held this position since 1989. Before this, he was the Company's Vice President for Scientific Affairs. Dr. Kelker has authored numerous scientific papers and presentations in the biotechnology field. He is a member of American Society of Microbiology and the American Association of the Advancement of Science. Dr. Kelker received his Ph.D. in Microbiology and Public Health from Michigan State University.

Organization Position Status
Enzo Biochem Inc. Senior Vice President Current
Dolan DNA Learning Center Senior Vice President at Enzo Biochem Current
Enzo Clinical Labs Inc. Current
Dolan DNA Learning Center Board of Directors Current
Enzo Biochem Inc. Board of Directors Current
Michigan State University Ph.D. In Microbiology and Public Health Former

Organization Position Status
Enzo Biochem Inc. Vice President, Corp Dev Current
Enzo Clinical Labs Inc. Current
Enzo Biochem Inc. Board of Directors Current
Enzo Therapeutics Inc. Vice President of Clinical Affairs Former
Columbia University Post Doctoral Fellowship Former
Yale University Master of Science Degree In Biochemistry Former

Organization Position Status
Enzo Biochem Inc. Vice President, Business Dev Current
Enzo Clinical Labs Inc. Current
Enzo Biochem Inc. Board of Directors Current
Gallard-Schlesinger Industries, Inc. Former
New York University Master of Business Administration In Finance Former
Rutgers University Master of Science Degree In Microbiology Former

Organization Position Status
Enzo Biochem Inc. Vice President, Finance Current
Enzo Biochem Inc. Board of Directors Current
Enzo Clinical Labs Inc. Senior Vice President Former
Baruch College Bachelor of Business Administration degree in Accounting Former

Organization Position Status
Enzo Biochem Inc. Lead Director Current
Parente Randolph LLC Attorney Current
Enzo Clinical Labs Inc. Current
Arbor Realty Trust, Inc. Chairman Current
Arbor Mortgage Director Current
Enzo Biochem Inc. Board of Directors Current
Arbor Realty Trust, Inc. Board of Directors Current
CECO Environmental Corp. Board of Directors Current
Lazar Levine & Felix Llp Founder Former

Organization Position Status
Enzo Biochem Inc. General Counsel Current
Enzo Clinical Labs Inc. Current
Enzo Biochem Inc. Board of Directors Current
Amster Rothstein and Ebenstein, Llp Former
United States Court of Appeals for the Federal Circuit Former
New York Law School Juris Doctorate Former
City University of New York Doctorate from New York Law School and her Bachelor's Degree in Biology Former
Queens College Bachelor's Degree In Biology Former

Organization Position Status
Imirus Chairman Current
Cleveland BioLabs, Inc. Chairman of The Board Current
SeraCare Life Sciences, Inc. Director Current
Enzo Biochem Inc. Director Current
SeraCare Life Sciences, Inc. Member Current
Siga,Inc. Chief Executive Officer Former
SIGA Technologies, Inc. CEO Former
Medplus, Inc. Chief Laboratory Officer Former
Medplusinc.Com Chief Laboratory Officer Former
Medplus, Inc. Vice President of Medical Affairs Former
Quest Diagnostics Incorporated Vice President of Business Development Former
Medplusinc.Com Vice President of Medical Affairs Former
Cleveland BioLabs, Inc. Director Former
SIGA Technologies, Inc. Board of Directors Former
Miami University Former
The Ohio State University College of Medicine Former

Organization Position Status
Enzo Biochem Inc. Board of Directors Current
Lark Technologies, Inc. CEO Former
Enzo Biochem Inc. President, Life Sciences Former
The University of Arizona Ph.D. In Genetics Former
The University of Arizona BS Degree In Biology Former

Organization Position Status
Pharmcentric Board of Directors Current
Enzo Biochem Inc. Board of Directors Current
Rheologics, Inc. Board of Directors Current
Sapphire Therapeutics, Inc. CEO Former
Enzo Therapeutics Inc. President Former
Sapphire Therapeutics, Inc. President Former
The Medicines Company Vice President, Cardiovascular Business Unit Former
SmithKline Beecham Corporation Former
Medical College of Virginia Bachelor of Science In Pharmacy Former

Organization Position Status
Enzo Clinical Labs Inc. Current
Enzo Biochem Inc. Board of Directors Current
Andrx Corporation Board of Directors Current
Andrx Corporation Director Former
Long Island University Board of Directors Former
Fordham University Bachelor of Science In Pharmacy Former

Organization Position Status
Deltacom, Inc. Executive Vice President and Chief Financial Officer of Rel Consultancy Group Current
Tier Technologies Inc. Director Nominee Current
Enzo Clinical Labs Inc. Current
Enzo Biochem Inc. Board of Directors Current
Endo Pharmaceuticals Holdings Inc. Board of Directors Current
Tier Technologies Inc. Board of Directors Current
British Energy Group plc Board of Directors Current
Deltacom, Inc. Board of Directors Current
Lexington Group President Former
Trump Management Inc. President Former
Lexington Group Cfo Former
Coty, Inc. Chief Financial Officer Former
Trump Management Inc. CFO Former
Coty, Inc. Executive Vice President, Finance & Administration Former
Trump Management Inc. Senior Vice President, Finance Former
Kraft Foods Inc. Senior Vice President Former
Trump Management Inc. Vice President, Finance Former
Avco Corporation Vice President Former
Textron Inc. Vice President Former
Lexington Group Managing Director Former
Trump Management Inc. Managing Director Former
Kraft Foods Inc. managing director Former
British Energy Group plc Deputy Chairman Former
Avco Corporation Treasurer Former
Fairleigh Dickinson University MBA Former
Bloomfield College BA In Business Administration Former
Fairleigh Dickinson University B.A. Degree Former

Organization Position Status
Enzo Clinical Labs Inc. Current
Patent Bar Board of Directors Current
Enzo Biochem Inc. Board of Directors Current
Patent Bar Member Current
Northeastern University Doctorate from Northeastern School of Law Former
Northeastern University Master of Science Degree In Biochemistry and Molecular Biology Former

Steven Kent, Ph. D was appointed to the Board in January, 2007. Dr. Kent is a University of Chicago Professor of Biochemistry and Molecular Biology, and Director of the University's Institute for Biophysical Dynamics, as a director. In addition to receiving numerous honors, and serving on various scientific advisory boards, including that of the Biosciences Division at Argonne National Laboratory, Dr. Kent is the holder of 37 United States patents.

Organization Position Status
Enzo Biochem Inc. Board of Directors Current
Victoria University Board of Directors Former
University of California, Berkeley PH.D. Former
University of California, Berkeley Master of Science Degrees Former
University of California, Berkeley B.Sc. Former
University of California, Berkeley Degree Former
advertisement
     ENZ $5.38 -0.04 (-0.74% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 178,752
Shares Outstanding 37.85M
Market Cap 203.7M
Year High 7.98
Year Low 2.7
Earnings Per Share 0.63
P/E Ratio 8.54
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here